Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-04-02 00:00 Tx date 2024-04-01 |
$VM
Voyageur Pharmaceuticals Ltd. |
Hesje, Ralph Curtis
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+125,651 vol |
704,372 | |
Filed 2024-04-01 23:58 Tx date 2024-04-01 |
$VM
Voyageur Pharmaceuticals Ltd. |
Hesje, Ralph Curtis
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+78,360 vol |
578,721 | |
Filed 2023-12-20 12:17 Tx date 2023-12-19 |
$VM
Voyageur Pharmaceuticals Ltd. |
Hesje, Ralph Curtis
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
97 - Other
|
+118,147 vol |
500,361 | |
Filed 2023-07-18 23:33 Tx date 2023-07-10 |
$VM
Voyageur Pharmaceuticals Ltd. |
Hesje, Ralph Curtis
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+76,672 vol |
382,214 | |
Filed 2023-04-10 18:56 Tx date 2023-04-10 |
$VM
Voyageur Pharmaceuticals Ltd. |
Hesje, Ralph Curtis
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+65,735 vol |
305,542 | |
Filed 2023-04-10 18:50 Tx date 2023-04-10 |
$VM
Voyageur Pharmaceuticals Ltd. |
Hesje, Ralph Curtis
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+6,250 vol |
||
Filed 2023-01-16 10:25 Tx date 2023-01-16 |
$VM
Voyageur Pharmaceuticals Ltd. |
Hesje, Ralph Curtis
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
97 - Other
|
+76,758 vol |
239,807 | |
Filed 2023-01-16 10:24 Tx date 2022-11-01 |
$VM
Voyageur Pharmaceuticals Ltd. |
Hesje, Ralph Curtis
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
97 - Other
|
+62,661 vol |
163,049 | |
Filed 2023-01-16 10:18 Tx date 2023-01-16 |
$VM
Voyageur Pharmaceuticals Ltd. |
Hesje, Ralph Curtis
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
97 - Other
|
+6,250 vol |
||
Filed 2022-11-07 10:10 Tx date 2022-11-01 |
$VM
Voyageur Pharmaceuticals Ltd. |
Hesje, Ralph Curtis
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
97 - Other
|
$625.00
+6,250 vol $0.10 each |
||
Filed 2022-11-07 10:10 Tx date 2022-11-01 |
$VM
Voyageur Pharmaceuticals Ltd. |
Hesje, Ralph Curtis
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
97 - Other
|
$625.00
+6,250 vol $0.10 each |
106,638 | |
Filed 2022-07-12 18:15 Tx date 2022-07-06 |
$VM
Voyageur Pharmaceuticals Ltd. |
Hesje, Ralph Curtis
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
97 - Other
|
+57,691 vol |
100,388 | |
Filed 2022-04-21 09:49 Tx date 2021-07-28 |
$VM
Voyageur Pharmaceuticals Ltd. |
Hesje, Ralph Curtis
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
00 - Opening Balance-Initial SEDI Report
|
42,697 | ||
Filed 2022-04-21 09:45 Tx date 2021-07-28 |
$VM
Voyageur Pharmaceuticals Ltd. |
Hesje, Ralph Curtis
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-01-20 12:26 Tx date 2022-01-17 |
$VM
Voyageur Pharmaceuticals Ltd. |
Hesje, Ralph Curtis
4 - Director of Issuer
Direct Ownership
|
Options
97 - Other
|
+74,532 vol |
225,796 | |
Filed 2022-01-04 15:52 Tx date 2021-12-30 |
$VM
Voyageur Pharmaceuticals Ltd. |
Hesje, Ralph Curtis
4 - Director of Issuer
Direct Ownership
|
Options
97 - Other
|
$4,972
+51,264 vol $0.097 each |
151,264 | |
Filed 2022-01-04 15:44 Tx date 2021-07-28 |
$VM
Voyageur Pharmaceuticals Ltd. |
Hesje, Ralph Curtis
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 |